AP1G1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.458000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.416400E-01
Normal-vs-Stage2
3.564600E-01
Normal-vs-Stage3
4.151800E-02
Normal-vs-Stage4
9.061600E-01
Stage1-vs-Stage2
4.152200E-01
Stage1-vs-Stage3
1.667600E-02
Stage1-vs-Stage4
6.183600E-01
Stage2-vs-Stage3
3.505700E-02
Stage2-vs-Stage4
2.128400E-01
Stage3-vs-Stage4
3.142300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.126000E-01
Normal-vs-AfricanAmerican
9.899600E-01
Normal-vs-Asian
2.019600E-01
Caucasian-vs-AfricanAmerican
1.715180E-01
Caucasian-vs-Asian
2.343600E-01
AfricanAmerican-vs-Asian
1.387820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.145600E-01
Normal-vs-Female
4.075200E-01
Male-vs-Female
5.199800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.736000E-01
Normal-vs-Age(41-60Yrs)
6.581400E-01
Normal-vs-Age(61-80Yrs)
2.458400E-01
Normal-vs-Age(81-100Yrs)
2.894600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.612600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.799600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.784800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.238400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.148160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.920600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.622800E-01
Normal-vs-Daily Drinker
1.193250E-01
Normal-vs-Weekly Drinker
2.228600E-01
Normal-vs-Occasional Drinker
7.578400E-01
Normal-vs-Social Drinker
6.264400E-01
Non Drinker-vs-Daily Drinker
4.439800E-01
Non Drinker-vs-Weekly Drinker
6.782200E-01
Non Drinker-vs-Occasional Drinker
2.892400E-02
Non Drinker-vs-Social Drinker
5.734400E-02
Daily Drinker-vs-Weekly Drinker
8.462200E-01
Daily Drinker-vs-Occasional Drinker
1.072020E-02
Daily Drinker-vs-Social Drinker
2.114400E-02
Weekly Drinker-vs-Occasional Drinker
4.987600E-02
Weekly Drinker-vs-Social Drinker
7.740000E-02
Occasional Drinker-vs-Social Drinker
8.034800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.558300E-02
Normal-vs-Grade 2
1.341620E-03
Normal-vs-Grade 3
7.228600E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.975000E-01
Grade 1-vs-Grade 3
1.336980E-01
Grade 1-vs-Grade 4
2.558300E-02
Grade 2-vs-Grade 3
9.511600E-02
Grade 2-vs-Grade 4
1.341620E-03
Grade 3-vs-Grade 4
7.228600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.510950E-01
Normal-vs-NonDiabetic
2.937000E-01
Diabetic-vs-NonDiabetic
1.536030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.511200E-01
Normal-vs-NoPancreatitis
2.605800E-01
Pancreatitis-vs-NoPancreatitis
8.969600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.897600E-01
Normal-vs-N1
3.519200E-01
N0-vs-N1
9.695600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.496600E-01
Normal-vs-TP53-NonMutant
5.706800E-01
TP53-Mutant-vs-TP53-NonMutant
3.037600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
